Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease

Brain

Volumn 139, Issue 1, 2016, Pages 161-173

  Zhang, Jiaxiang ^a,b   Rittman, Timothy ^c   Nombela, Cristina ^c   Fois, Alessandro ^c   Coyle Gilchrist, Ian ^c   Barker, Roger A ^c   Hughes, Laura E ^b,c   Rowe, James B ^b,c,d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bayesian hierarchical model; Drift diffusion model; Parkinson's disease; Progressive supranuclear palsy; Saccadic inhibition

Indexed keywords

AGED; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; FEMALE; HUMAN; LATENT PERIOD; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SACCADIC EYE MOVEMENT; BAYES THEOREM; BIOLOGICAL MODEL; CASE CONTROL STUDY; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PSYCHOLOGY;

AGED; BAYES THEOREM; CASE-CONTROL STUDIES; DECISION MAKING; FEMALE; HUMANS; MALE; MODELS, NEUROLOGICAL; NEURAL INHIBITION; PARKINSON DISEASE; SACCADES; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84964688295     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv331     Document Type: Article

References (100)

1. Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:42-9.
2. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res 1990;85:119-46.
3. Amador SC, Hood AJ, Schiess MC, Izor R, Sereno AB. Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients. Neuropsychologia 2006;44:1475-82.
4. Antoniades C, Ettinger U, Gaymard B, Gilchrist I, Kristjánsson A, Kennard C, et al. An internationally standardised antisaccade protocol. Vision Res 2013;84:1-5.
5. Averbeck BB, O'Sullivan SS, Djamshidian A. Impulsive and compulsive behaviors in Parkinson's disease. Annu Rev Clin. Psychol 2014;10:553-80.
6. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
7. Berger JO, Bayarri MJ. The interplay of bayesian and frequentist analysis. Stat Sci 2004;19:58-80.
8. Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of Gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord 2004;19:871-84.
9. Boucher L, Stuphorn V, Logan GD, Schall JD, Palmeri TJ. Stopping eye and hand movements: are the processes independent? Percept Psychophys 2007;69:785-801.
10. Braak H, Del Tredici K, Rüb U, De Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
11. Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004;75:246-9.
12. Briand KA, Hening W, Poizner H, Sereno AB. Automatic orienting of visuospatial attention in Parkinson's disease. Neuropsychologia 2001;39:1240-9.
13. Briand KA, Strallow D, Hening W, Poizner H, Sereno AB. Control of voluntary and reflexive saccades in Parkinson's disease. Exp Brain Res 1999;129:38-48.
14. Brunton BW, Botvinick MM, Brody CD. Rats and humans can optimally accumulate evidence for decision-making. Science 2013;340:95-8.
15. Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 2014;29:684-93.
16. Cavanagh JF, Wiecki TV, Cohen MX, Figueroa CM, Samanta J, Sherman SJ, et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci 2011;14:1462-7.
17. Chan F, Armstrong IT, Pari G, Riopelle RJ, Munoz DP. Deficits in saccadic eye-movement control in Parkinson's disease. Neuropsychologia 2005;43:784-96.
18. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011;69:680-94.
19. Van Donkelaar P, Siu KC, Walterschied J. Saccadic output is influenced by limb kinetics during eye-hand coordination. J Mot Behav 2004;36:245-52.
20. Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008;23:727-33.
21. Everling S, Paré M, Dorris MC, Munoz DP. Comparison of the discharge characteristics of brain stem omnipause neurons and superior colliculus fixation neurons in monkey: implications for control of fixation and saccade behavior. J Neurophysiol 1998;79:511-28.
22. Fahn S. Recent developments in Parkinson's disease. New York: Raven Press; 1986.
23. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007;318:1309-12.
24. Gamerman D, Lopes HF. Markov chain monte carlo: stochastic simulation for bayesian inference. 2nd edn. London: Taylor and Francis; 2006.
25. Garbutt S, Riley DE, Kumar AN, Han Y, Harwood MR, Leigh RJ. Abnormalities of optokinetic nystagmus in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004;75:1386-94.
26. Gauggel S, Rieger M, Feghoff TA. Inhibition of ongoing responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:539-44.
27. Gauntlett-Gilbert J, Brown VJ. Reaction time deficits and Parkinson's disease. Neurosci Biobehav Rev 1998;22:865-81.
28. Gelman A, Carlin J, Stern H, Rubin D. Bayesian data analysis. 2nd edn. Boca Raton, FL: Chapman & Hall/CRC Press; 2004.
29. Ghosh B, Rowe JB, Carpenter RHS, Calder AJ, Peers PV, Lawrence AD, et al. PAW20 Saccadic correlates of cognition in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2010;81:e29.
30. Ghosh BCP, Calder AJ, Peers PV, Lawrence AD, Acosta-Cabronero J, Pereira JM, et al. Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain 2012;135:2089-102.
31. Ghosh BCP, Carpenter RHS, Rowe JB. A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy. PLoS One 2013;8:e74486.
32. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
33. Gibson JM, Pimlott R, Kennard C. Ocular motor and manual tracking in Parkinson's disease and the effect of treatment. J Neurol Neurosurg. Psychiatry 1987;50:853-60.
34. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain 2007;130:1552-65.
35. Gomez P, Ratcliff R, Perea M. A model of the go/no-go task. J Exp Psychol Gen 2007;136:389-413.
36. Gopal A, Murthy A. Eye-hand coordination during a double-step task: evidence for a common stochastic accumulator. J Neurophysiol 2015;114:1438-54.
37. Gribble PL, Everling S, Ford K, Mattar A. Hand-eye coordination for rapid pointing movements: arm movement direction and distance are specified prior to saccade onset. Exp Brain Res 2002;145:372-82.
38. Hanes DP, Patterson WF, Schall JD. Role of frontal eye fields in countermanding saccades: visual, movement, and fixation activity. J Neurophysiol 1998;79:817-34.
39. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-19.
40. Helmich RC, de Lange FP, Bloem BR, Toni I. Cerebral compensation during motor imagery in Parkinson's disease. Neuropsychologia 2007;45:2201-15.
41. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 2000;80:953-78.
42. Jahanshahi M, Obeso I, Baunez C, Alegre M, Krack P. Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity. Mov Disord 2014;00:1-13.
43. Jahanshahi M. Effects of deep brain stimulation of the subthalamic nucleus on inhibitory and executive control over prepotent responses in Parkinson's disease. Front Syst Neurosci 2013;7:118.
44. Jahfari S, Ridderinkhof KR, Scholte HS. Spatial frequency information modulates response inhibition and decision-making processes. PLoS One 2013;8:e76467.
45. De Jong R, Coles MG, Logan GD, Gratton G. In search of the point of no return: the control of response processes. J Exp Psychol Hum Percept Perform 1990;16:164-82.
46. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003;210:57-60.
47. Kim JN, Shadlen MN. Neural correlates of a decision in the dorsolateral prefrontal cortex of the macaque. Nat Neurosci 1999;2:176-85.
48. Van Koningsbruggen MG, Pender T, Machado L, Rafal RD. Impaired control of the oculomotor reflexes in Parkinson's disease. Neuropsychologia 2009;47:2909-15.
49. Kruschke J. Doing Bayesian data analysis: a tutorial introduction with R and BUGS. San Diego, CA: Academic Press/Elsevier; 2010.
50. Leigh RJ, Kennard C. Using saccades as a research tool in the clinical neurosciences. Brain 2004;127:460-77.
51. Leung HC, Cai W. Common and differential ventrolateral prefrontal activity during inhibition of hand and eye movements. J Neurosci 2007;27:9893-9900.
52. Li M, Kuroiwa Y, Wang L, Kamitani T, Takahashi T, Suzuki Y, et al. Early sensory information processes are enhanced on visual oddball and S1-S2 tasks in Parkinson's disease: a visual event-related potentials study. Park Relat Disord 2003;9:329-40.
53. Linder J, Wenngren BI, Stenlund H, Forsgren L. Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism. J Neurol 2012;259:1206-14.
54. Lindley DV. Introduction to probability and statistics from a bayesian viewpoint. Cambridge: Cambridge University Press; 1965.
55. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996a;47:1-9.
56. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996b;55:97-105.
57. Lunenburger L, Kutz DF, Hoffmann KP. Influence of arm movements on saccades in humans. Eur J Neurosci 2000;12:4107-16.
58. Michell AW, Xu Z, Fritz D, Lewis SJG, Foltynie T, Williams-Gray CH, et al. Saccadic latency distributions in Parkinson's disease and the effects of L-dopa. Exp Brain Res 2006;174:7-18.
59. Mulder MJ, Wagenmakers EJ, Ratcliff R, Boekel W, Forstmann BU. Bias in the Brain: a diffusion model analysis of prior probability and potential payoff. J Neurosci 2012;32:2335-43.
60. Nombela C, Rittman T, Robbins TW, Rowe JB. Multiple modes of impulsivity in Parkinson's disease. PLoS One 2014;9:e85747.
61. O'Sullivan SS, Djamshidian A, Ahmed Z, Evans AH, Lawrence AD, Holton JL, et al. Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy. Mov Disord 2010;25:638-42.
62. Ober JK, Przedpelska-Ober E, Gryncewicz W, Dylak J, Carpenter RH, Ober JJ. Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Gajda J., editor. Modelling and Measurement in Medicine Komitet Biocybernityki i Inzyneierii Biomedycznej. Warsaw: PAN; 2003. p. 187-98.
63. Obeso I, Wilkinson L, Casabona E, Bringas ML, Alvarez M, Alvarez L, et al. Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Exp Brain Res 2011;212:371-84.
64. Obeso I, Wilkinson L, Casabona E, Speekenbrink M, Bringas ML, Alvarez M, et al. The subthalamic nucleus and inhibitory control: impact of subthalamotomy in Parkinson's disease. Brain 2014;137:1470-80.
65. Otero-Millan J, Serra A, Leigh RJ, Troncoso XG, Macknik SL, Martinez-Conde S. Distinctive features of saccadic intrusions and microsaccades in progressive supranuclear palsy. J Neurosci 2011;31:4379-87.
66. Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature 2006;443:768-73.
67. Paré M, Wurtz RH. Progression in neuronal processing for saccadic eye movements from parietal cortex area lip to superior colliculus. J Neurophysiol 2001;85:2545-62.
68. Perneczky R, Ghosh BCP, Hughes L, Carpenter RHS, Barker RA, Rowe JB. Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity. Neurobiol Dis 2011;43:79-85.
69. Pierrot-Deseilligny C, Rivaud S, Pillon B, Fournier E, Agid Y. Lateral visually-guided saccades in progressive supranuclear palsy. Brain 1989;112:471-87.
70. Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage 2012;62:1675-84.
71. Rascol O, Sabatini U, Simonetta-Moreau M, Montastruc JL, Rascol A, Clanet M. Square wave jerks in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 1991;54:599-602.
72. Ratcliff R, Cherian A, Segraves M. A comparison of macaque behavior and superior colliculus neuronal activity to predictions from models of two-choice decisions. J Neurophysiol 2003;90:1392-407.
73. Ratcliff R, Gomez P, McKoon G. A diffusion model account of the lexical decision task. Psychol Rev 2004;111:159-82.
74. Ratcliff R, McKoon G. The diffusion decision model: theory and data for two-choice decision tasks. Neural Comput 2008;20:873-922.
75. Ratcliff R, Smith PL. A comparison of sequential sampling models for two-choice reaction time. Psychol Rev 2004;111:333-67.
76. Ridderinkhof KR, Van Den Wildenberg WPM, Segalowitz SJ, Carter CS. Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn 2004;56:129-40.
77. Robert G, Drapier D, Verin M, Millet B, Azulay JP, Blin O. Cognitive impulsivity in Parkinson's disease patients: assessment and pathophysiology. Mov Disord 2009;24:2316-27.
78. Robinson FR, Fuchs AF. The role of the cerebellum in voluntary eye movements. Annu Rev Neurosci 2001;24:981-1004.
79. Rowe JB, Hughes L, Nimmo-Smith I. Action selection: a race model for selected and non-selected actions distinguishes the contribution of premotor and prefrontal areas. Neuroimage 2010;51:888-96.
80. Sailer U, Eggert T, Ditterich J, Straube A. Spatial and temporal aspects of eye-hand coordination across different tasks. Exp Brain Res 2000;134:163-73.
81. Shadlen MN, Newsome WT. Neural basis of a perceptual decision in the parietal cortex (Area LIP) of the rhesus monkey. J Neurophysiol 2001;86:1916-36.
82. Snyder LH, Calton JL, Dickinson AR, Lawrence BM. Eye-hand coordination: saccades are faster when accompanied by a coordinated arm movement. J Neurophysiol 2002;87:2279-86.
83. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B Stat Methodol 2002;64:583-639.
84. Swann N, Poizner H, Houser M, Gould S, Greenhouse I, Cai W, et al. Deep brain stimulation of the subthalamic nucleus alters the cortical profile of response inhibition in the beta frequency band: a scalp EEG study in Parkinson's disease. J Neurosci 2011;31:5721-29.
85. Tinaz S, Courtney MG, Stern CE. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011;26:436-41.
86. Vandekerckhove J, Tuerlinckx F, Lee MD. Hierarchical diffusion models for two-choice response times. Psychol Methods 2011;16:44-62.
87. Verbruggen F, Logan GD. Models of response inhibition in the stopsignal and stop-change paradigms. Neurosci Biobehav Rev 2009;33:647-61.
88. Vidailhet M, Rivaud S, Gouider-Khouja N, Pillon B, Bonnet AM, Gaymard B, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35:420-26.
89. Wagenmakers EJ. Methodological and empirical developments for the Ratcliff diffusion model of response times and accuracy. Eur J Cogn Psychol 2009;21:641-71.
90. Wang L, Kuroiwa Y, Li M, Wang J, Kamitani T. Do P1 and N1 evoked by the ERP task reflect primary visual processing in Parkinson's disease? Doc Ophthalmol 2001;102:83-93.
91. Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, Hodges J, et al. The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatry 2008;79:500-3.
92. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a crosssectional study of 3090 patients. Arch Neurol 2010;67:589-95.
93. Wiecki TV, Sofer I, Frank MJ. HDDM: Hierarchical Bayesian estimation of the Drift-Diffusion Model in Python. Front Neuroinform 2013;7:14.
94. Van den Wildenberg WPM, van Boxtel GJM, van der Molen MW, Bosch DA, Speelman JD, Brunia CHM. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease. J Cogn Neurosci 2006;18:626-36.
95. Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD Study. Neurology 2014;82:308-16.
96. Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, et al. Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease. Brain 2014a;137:1145-55.
97. Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, et al. Improving response inhibition in parkinson's disease with atomoxetine. Biol Psychiatry 2014b;77:740-8
98. Yugeta A, Terao Y, Fukuda H, Hikosaka O, Yokochi F, Okiyama R, et al. Effects of STN stimulation on the initiation and inhibition of saccade in parkinson disease. Neurology 2010;74:743-8.
99. Zhang J, Hughes LE, Rowe JB. Selection and inhibition mechanisms for human voluntary action decisions. Neuroimage 2012;63:392-402.
100. Zhang J, Rowe JB. Dissociable mechanisms of speed-accuracy tradeoff during visual perceptual learning are revealed by a hierarchical driftdiffusion model. Front. Neurosci 2014;8:1-13.